Skip to content
LodeRx
Get started
← All posts
TAG

glp-1

24 articles tagged glp-1.

Compounded Tirzepatide vs. Mounjaro: Understanding the 503A Pathway
tirzepatide

Compounded Tirzepatide vs. Mounjaro: Understanding the 503A Pathway

Compounded tirzepatide and brand-name Mounjaro differ in FDA status, sourcing, and oversight. Learn how the 503A pathway works before you evaluate options.

August 23, 2026
GLP-1 Off-Ramp Support: What Clinicians Offer Patients Stopping a Compounded GLP-1
glp-1

GLP-1 Off-Ramp Support: What Clinicians Offer Patients Stopping a Compounded GLP-1

What a structured off-ramp looks like when stopping a compounded GLP-1: tapering guidance, monitoring, and realistic expectations from clinicians.

August 19, 2026
Compounded Semaglutide vs. Compounded Tirzepatide: How to Frame the Choice With Your Clinician
glp-1

Compounded Semaglutide vs. Compounded Tirzepatide: How to Frame the Choice With Your Clinician

Compounded semaglutide vs compounded tirzepatide: how mechanism, weight-loss data, side effects, and FDA guidance should shape a conversation with a licensed clinician.

August 15, 2026
GLP-1s and Alcohol: What Patients Report and What Clinicians Commonly Advise
glp-1

GLP-1s and Alcohol: What Patients Report and What Clinicians Commonly Advise

What patients on GLP-1 medications report about drinking alcohol, what current research shows, and how clinicians typically guide these conversations.

August 12, 2026
Weekly vs. Microdosing Semaglutide: How Clinicians Approach Compounded Dosing Schedules
glp-1

Weekly vs. Microdosing Semaglutide: How Clinicians Approach Compounded Dosing Schedules

Clinicians compare once-weekly semaglutide titration with microdosing frameworks: evidence, risks, and how compounded doses are prescribed and dispensed.

August 10, 2026
Injection Site Rotation for TRT and GLP-1: What Clinicians Recommend
trt

Injection Site Rotation for TRT and GLP-1: What Clinicians Recommend

How clinicians recommend rotating TRT and GLP-1 injection sites to reduce scar tissue and support consistent absorption, with cited clinical sources.

August 10, 2026
GLP-1 Discontinuation and Weight Regain: What the Research Shows
glp-1

GLP-1 Discontinuation and Weight Regain: What the Research Shows

Research shows most people regain a majority of lost weight after stopping GLP-1 therapy. Here's what the studies say and what to discuss with a clinician.

August 7, 2026
Compounded GLP-1s After the Shortage: What Current 503A Rules Mean for Access
glp-1

Compounded GLP-1s After the Shortage: What Current 503A Rules Mean for Access

The national GLP-1 shortage has ended. Here's what FDA's 503A rules actually allow now, who still qualifies for compounded access, and how to check your options.

August 4, 2026
How Clinicians Typically Escalate a Compounded GLP-1 Dose
glp-1

How Clinicians Typically Escalate a Compounded GLP-1 Dose

How do clinicians titrate compounded GLP-1 doses? A look at typical escalation schedules, why slow titration matters, and what changes the pace.

August 2, 2026
Compounded GLP-1s and Muscle: What the Research Says About Lean Mass Retention
glp-1

Compounded GLP-1s and Muscle: What the Research Says About Lean Mass Retention

Compounded GLP-1 therapy and lean mass loss, explained through current research on resistance training, protein intake, and monitoring strategies.

August 2, 2026
Compounded Semaglutide vs. Ozempic: What "Compounded" Actually Means
glp-1

Compounded Semaglutide vs. Ozempic: What "Compounded" Actually Means

Compounded semaglutide is not Ozempic. Here's what compounding actually means, how it differs from FDA regulatory review, and what to ask before starting.

August 2, 2026
Men's Health Bloodwork: Which Panels Match Which Goals
bloodwork

Men's Health Bloodwork: Which Panels Match Which Goals

A guide to men's bloodwork by goal: baseline wellness, TRT candidacy, GLP-1 monitoring, and longevity panels, with what each test measures and why.

August 2, 2026